Abstract
Synovial sarcoma of the digestive tract, including that of the esophagus, is extremely rare. To our knowledge, only 9 cases of primary synovial sarcoma of the esophagus have been reported worldwide. Here, we describe the case of a 70-year-old man who presented with dysphagia and hoarseness, which he had been experiencing for 4 months. A pigmented polypoid mass was detected at the cervical esophagus and spindle cell sarcoma was suspected on the basis of biopsy findings. Two operations were performed to completely excise both the tumor and regional lymph nodes. The tumor was diagnosed as a biphasic synovial sarcoma on the basis of the detection of SYT-SSX1 fusion transcripts by reverse transcription-polymerase chain reaction and fluorescence in situ hybridization. Twenty-two months following surgery, the patient developed local recurrence and received radiotherapy with 60 Gy in 30 fractions. Post-treatment follow-up uncovered the presence of left cervical lymph node metastases that were then removed. Approximately 1 month after resection, multiple metastases developed in the lungs. At his request, the patient did not receive any chemotherapy and died at 42 months after the first operation.
Similar content being viewed by others
References
Thomas RM, Sobin LH, et al. Gastrointestinal cancer. Cancer. 1995;75(1 Suppl):154–70.
Palmer BV, Levene A, Shaw HJ, et al. Synovial sarcoma of the pharynx and oesophagus. J Laryngol Otol. 1983;97(12):1173–6.
Amr SS, Shihabi NK, Al Hajj H, et al. Synovial sarcoma of the esophagus. Am J Otolaryngol. 1984;5(4):266–9.
Bloch MJ, Iozzo RV, Edmunds LH Jr, Brooks JJ, et al. Polypoid synovial sarcoma of the esophagus. Gastroenterology. 1987;92(1):229–33.
Antón-Pacheco J, Cano I, Cuadros J, Vilariño A, Berchi F, et al. Synovial sarcoma of the esophagus. J Pediatr Surg. 1996;31(12):1703–5.
Habu S, Okamoto E, Toyosaka A, Nakai Y, Takeuchi M, et al. Synovial sarcoma of the esophagus: report of a case. Surg Today. 1998;28(4):401–4.
Bonavina L, Fociani P, Asnaghi D, Ferrero S, et al. Synovial sarcoma of the esophagus simulating achalasia. Dis Esophagus. 1998;11(4):268–71.
Billings SD, Meisner LF, Cummings OW, Tejada E, et al. Synovial sarcoma of the upper digestive tract: a report of two cases with demonstration of the X;18 translocation by fluorescence in situ hybridization. Mod Pathol. 2000;13(1):68–76.
Butori C, Hofman V, Attias R, Mouroux J, Pedeutour F, Hofman P, et al. Diagnosis of primary esophageal synovial sarcoma by demonstration of t(X;18) translocation: a case report. Virchows Arch. 2006;449(2):262–7.
de Alencar MH, Boldrini D, Costa Ade M, Torres de Oliveira AT, Attab CS, et al. Primary synovial sarcoma of the esophagus. Rev Col Bras Cir (article in Portuguese). 2012;39(5):441–3.
Knösel T, Heretsch S, Altendorf-Hofmann A, Richter P, Katenkamp K, Katenkamp D, Berndt A, Petersen I, et al. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Eur J Cancer. 2010;46(6):1170–6.
Limon J, Dal Cin P, Sandberg AA. Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11). Cancer Genet Cytogenet. 1986;23(1):87–91.
Turc-Carel C, Dal Cin P, Limon J, Li F, Sandberg AA, et al. Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet. 1986;23(1):93.
Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998;338(3):153–60.
Saito T, Nagai M, Ladanyi M, et al. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma. Cancer Res. 2006;66(14):6919–27.
Eilber FC, Eilber FR, Eckardt J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg. 2004;240:686–95.
Canter RJ, Qin LX, Maki RG, Brennan MF, Ladanyi M, Singer S, et al. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. 2008;14(24):8191–7.
van der Graaf WT, Blay JY, Chawla SP, Kim DW, Bui-Nguyen B, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012;379(9829):1879–86.
Kawaguchi S, Tsukahara T, Ida K, Kimura S, Murase M, et al. SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group. Cancer Sci. 2012;103(9):1625–30.
Ethical Statement
This article does not contain any studies with human or animal subjects performed by any authors.
Conflict of interest
We do not have any financial disclosures to make or any conflicts of interest to report.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niihara, M., Sato, H., Kusafuka, K. et al. Biphasic synovial sarcoma of the cervical esophagus confirmed by the presence of SYT-SSX1 fusion transcripts. Esophagus 12, 251–257 (2015). https://doi.org/10.1007/s10388-014-0419-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-014-0419-7